Nielsen H, Rossi M, Lefèvre J P. "一种克唑替尼杂质48的合成方法" [P]. European Patent, EP 3524999 A1, 2022-07-17.
Johansson L, Martínez F, Mueller T C. "Method for the Synthesis of Crizotinib Impurity 48" [P]. European Patent, EP 3362221 A1, 2025-08-27.
Kowalski A, Johansson L, Martínez F. "A Process for Preparing High-Purity Crizotinib Impurity 48" [P]. European Patent, EP 3306228 A1, 2020-11-15.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 克唑替尼杂质48 in Pharmaceutical Formulations". Anal. Chem., 2025, 1079, (6), 9454-9469.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 克唑替尼杂质48 as an Impurity". J. Chromatogr. A, 2012, 1480, (4), 3091-3107.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Crizotinib Impurity 48 Using HRMS and NMR". Chemosphere, 2022, 542, (8), 3981-3993.